Get the Stockscreener App
1.20
0.84%
0.01
After Hours:
1.22
0.02
+1.67%
Neuronetics Inc stock is traded at $1.20, with a volume of 2.57M.
It is up +0.84% in the last 24 hours and down -24.53% over the past month.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
See More
Previous Close:
$1.19
Open:
$1.19
24h Volume:
2.57M
Relative Volume:
1.18
Market Cap:
$83.51M
Revenue:
$151.64M
Net Income/Loss:
$-37.23M
P/E Ratio:
-3.0659
EPS:
-0.3914
Net Cash Flow:
$-21.18M
1W Performance:
-6.25%
1M Performance:
-24.53%
6M Performance:
-8.40%
1Y Performance:
-69.92%
1-Day Range:
$1.19
$1.28
1-Week Range:
$1.115
$1.29
52-Week Range:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.20 | 82.81M | 151.64M | -37.23M | -21.18M | -0.3914 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics Analyst Ratings and Price Targets | NASDAQ:STIM - Benzinga
Neuronetics Inc (STIM) Stock Price, Quote, News & History - Benzinga
Neuronetics, Inc. Signs $26,000/Month Consulting Agreement with Francis X. Brown III – 8-K Filing Details and Agreement Terms - Minichart
Neuronetics updates consulting agreement for interim financial officer - Investing.com
Neuronetics updates consulting agreement for interim financial officer By Investing.com - Investing.com UK
Neuronetics (NASDAQ: STIM) sets new monthly pay for interim finance chief - Stock Titan
STIM Stock Price, Quote & Chart | NEURONETICS INC (NASDAQ:STIM) - ChartMill
Neuronetics (STIM) ex-CFO corrects insider sale to 8,569 tax-withheld shares - Stock Titan
STIM PE Ratio & Valuation, Is STIM Overvalued - Intellectia AI
STIM SEC FilingsNeuronetics 10-K, 10-Q, 8-K Forms - Stock Titan
Insider Buying: Jorey Chernett Acquires 100,000 Shares of Neuron - GuruFocus
Neuronetics 10% owner Chernett buys $117,000 in common stock - Investing.com UK
Neuronetics 10% owner Chernett buys $117,000 in common stock By Investing.com - Investing.com Australia
Neuronetics (NASDAQ: STIM) large holder buys 100,000 shares - Stock Titan
Neuronetics(STIM) Stock Options Chain | Quotes & News - Moomoo
Neuronetics stock (US63009R1005): earnings move puts focus back on growth outlook - AD HOC NEWS
Neuronetics Revenue Rises as Clinic Business Expands - MyChesCo
Neuronetics partners with ANT Neuro on neuronavigation tech By Investing.com - Investing.com South Africa
Neuronetics and Ant Neuro announce strategic collaboration to integrate neuronavigation with Neurostar TMS treatment - marketscreener.com
Neuronetics partners with ANT Neuro on neuronavigation tech - Investing.com India
Neuronetics And Ant Neuro Announce Strategic Collaboration To Integrate Neuronavigation With Neurostar Tms Treatment - TradingView
Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment - The Manila Times
Neuronetics (STIM) interim PAO reports 19,968 Common Stock shares - Stock Titan
Insider Buying: Jorey Chernett Acquires 475,000 Shares of Neuron - GuruFocus
Neuronetics: Jorey Chernett buys $636,500 in shares By Investing.com - Investing.com India
Neuronetics: Jorey Chernett buys $636,500 in shares - Investing.com UK
Neuronetics Insider Bought Shares Worth $636,500, According to a Recent SEC Filing - marketscreener.com
Neuronetics 10% Owner Purchased Shares Worth Over $636K - TradingView
Neuronetics | 4: Statement of changes in beneficial ownership of securities-10% Owner Chernett Jorey - Moomoo
Large Neuronetics (STIM) shareholder adds 475,000 shares in open-market buy - Stock Titan
Neuronetics stock (US63009R1005): Innovative Neurostimulation Leader - AD HOC NEWS
MSN Money - MSN
Neuronetics (STIM) Q1 2026 Earnings Transcript - AOL.com
Neuronetics outlines $160M-$166M 2026 revenue outlook with focus on $2.5M-$3M annualized cost savings - MSN
Full Transcript: Neuronetics Q1 2026 Earnings Call - Sahm
Neuronetics, Inc. (NASDAQ:STIM) Q1 2026 Earnings Call Transcript - Insider Monkey
Neuronetics Q1 2026 slides: revenue rises 8% amid profitability push By Investing.com - Investing.com Australia
Geopolitical Turmoil and Supply Chain Strains Threaten Neuronetics’ Costs, Margins, and Growth - TipRanks
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):